Vimab Group AB (publ) (OM:VIMAB) signed letter of intent to acquire Solomon Oy for â¬2.3 million on June 20, 2023. Initial purchase price of â¬1.8 million includes â¬0.5 million in cash, â¬1.3 million in Vimab shares. Signing of share transfer agreement is planned for Q3 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.35 SEK | +0.54% | +2.75% | +5.53% |
May. 08 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
1st Jan change | Capi. | |
---|---|---|
+5.53% | 19.94M | |
+9.01% | 7.61B | |
-34.90% | 3.09B | |
+4.71% | 2.63B | |
-4.14% | 1.5B | |
-15.85% | 1.01B | |
+10.34% | 761M | |
-13.73% | 669M | |
-2.77% | 611M | |
-10.83% | 592M |
- Stock Market
- Equities
- VIMAB Stock
- News Vimab Group AB
- Vimab Group AB (OM: VIMAB) signed letter of intent to acquire Solomon Oy for €2.3 million.